Drug profile · INN
etidocaine hydrochloride
DURANEST
etidocaine hydrochloride (DURANEST) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Drug details — etidocaine hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
etidocaine hydrochloride (DURANEST) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium channel alpha subunit blocker
Primary target: Sodium channel alpha subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is etidocaine hydrochloride?
etidocaine hydrochloride (DURANEST) is a sodium channel alpha subunit blocker. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for etidocaine hydrochloride?
DURANEST is a marketed brand name for etidocaine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of etidocaine hydrochloride?
etidocaine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.